A number of research firms have changed their ratings and price targets for Sartorius (FRA: SRT3):

  • 4/18/2019 – Sartorius was given a new €107.00 ($124.42) price target on by analysts at Kepler Capital Markets. They now have a “sell” rating on the stock.
  • 4/18/2019 – Sartorius was given a new €147.00 ($170.93) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 4/18/2019 – Sartorius was given a new €153.50 ($178.49) price target on by analysts at Warburg Research. They now have a “neutral” rating on the stock.
  • 4/11/2019 – Sartorius was given a new €150.00 ($174.42) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 4/4/2019 – Sartorius was given a new €130.00 ($151.16) price target on by analysts at Hauck & Aufhaeuser. They now have a “sell” rating on the stock.
  • 2/22/2019 – Sartorius was given a new €115.00 ($133.72) price target on by analysts at Berenberg Bank. They now have a “sell” rating on the stock.

Shares of SRT3 traded up €0.80 ($0.93) during trading hours on Monday, reaching €152.90 ($177.79). 172,318 shares of the company traded hands. Sartorius AG has a 12 month low of €71.00 ($82.56) and a 12 month high of €124.70 ($145.00).

Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors.

Recommended Story: Do back-end load funds outperform no-load funds?

Receive News & Ratings for Sartorius AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius AG and related companies with MarketBeat.com's FREE daily email newsletter.